Clinical Academic Building (CAB)
The Scleroderma Program encompasses a comprehensive consultation for systemic sclerosis and related disorders. Referrals from rheumatologists are preferred. Initial consultation scheduling is triaged according to the gravity of illness and protocol eligibility. Multiple clinical research protocols are available, including disease-modifying agents for early diffuse disease, therapies for interstitial lung disease and new agents for severe Raynaud's phenomenon. Other protocols are available for rheumatoid arthritis and other complex disorders.
Participating RWJUMG Physicians
Department of Medicine